Fachklinik Bad Bentheim
- Address
- Am Bade 1, 48455 Bad Bentheim, Germany
Chronic Venous Ulcer Healing
The Fachklinik Bad Bentheim conducts research in skin and connective tissue diseases, focusing on chronic venous ulcer to evaluate a new topical agent that aims to speed wound closure while ensuring safety.
- Topical dose‑response assessment
- Placebo‑controlled efficacy measurement
- Monitoring of adverse events
- Patient‑reported wound healing outcomes
This work at the Bad Bentheim site seeks to provide faster, safer healing options for patients with therapy‑resistant ulcers.
Prurigo Nodularis Itch Management
In the area of skin and connective tissue diseases, the clinic investigates prurigo nodularis using an investigational monoclonal antibody designed to reduce severe itching and improve quality of life.
- Double‑blind efficacy evaluation
- Numeric rating scale for itch intensity
- Open‑label safety extension phase
- Assessment of patient‑reported symptom relief
The study at Fachklinik Bad Bentheim aims to deliver a novel therapeutic option for individuals struggling with persistent pruritic skin lesions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Fachklinik Bad Bentheim
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of Allogeneic Skin-Derived ABCB5-Positive Dermal Mesenchymal Stromal Cells in Therapy-Resistant Chronic Venous Ulcers | Rheacell GmbH & Co. KG | Phase II | Not Recruiting | Aug 2021 | Nov 2025 |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Allogeneic Skin-Derived Abcb5-Positive Dermal Mesenchymal Stromal Cells | 1 | Unknown | 2021-08-18 | 2021-08-18 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.